David Kahn in Surprise, Arizona

Home Arizona Surprise

David Kahn has Hematology/oncology as his primary medical specialty. Their primary office is: 14780 W Mountain View Blvd in Surprise, Arizona. There is an additional office location, for a total of two, for David Kahn that can be viewed further down. They attended University Of Arizona College Of Medicine and graduated in 2004 (around 20 years of experience). They are listed as doing telehealth appointments.

David Y Kahn Office Phone and Directions

David Kahn
14780 W Mountain View Blvd
Surprise, Arizona 85374
623-215-9760

Patient Ratings
Please rate your experience with David Kahn below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 623-215-9760

Enter a starting address:

Healthcare Info for David Kahn

Medical School: University Of Arizona College Of Medicine
Graduation Year: 2004
The Primary Medical Specialty for David Kahn is listed as: Hematology/oncology
Approximate Years of Experience: 20
PAC (PECOS ID)#: 3173696036
NPI #: 1942421334
NPI Created On: 05/01/2007
NPI Last Updated Listed as: 08/10/2022
Primary Taxonomy Code: 207RX0202X
License Number:
34595
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 60 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, ferric carboxymaltose, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011511

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819050225

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERBITUX

Open Associated Drug #1: 66733-958-23

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: CYRAMZA

Associated Drug #2: 0002-7669-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819065482

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832145055

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832145057

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $120

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832145061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832145065

Being Disputed:: No

Product Related: No

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783704175

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology

Name of Drug #1: Revlimid

Open Associated Drug #1: 59572-405-28

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783704177

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783704179

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ABECMA

Open Associated Drug #1: 59572-515-01

Additional Office Locations

1. American Oncology Partners Pa
14780 W Mountain View Blvd
Surprise, AZ 85374
Suite 211
Group Members: 188

Phone: 623-215-9760

Enter a starting address:

Hematology/oncology Professionals in Surprise

1.
Devinder Singh

14674 W Mountain View Blvd
Surprise, AZ
Honorhealth Ambulatory

2.
Anjali Iyengar

14674 W Mountain View Blvd
Surprise, AZ
Honorhealth Ambulatory

3.
Parmjeet Banghar MD

14674 W Mountain View Blvd
Surprise, AZ
Honorhealth Ambulatory

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry